# AlgoMeds specialty and role workflows

Source: https://algomeds.com/solutions/

## Patient assistance program software for primary care practices

[Primary care workflow](https://algomeds.com/solutions/primary-care/)

Primary care practices file more manufacturer patient assistance applications than any other setting, and almost none of them have a coordinator whose job it is. AlgoMeds fills the manufacturer form from records the practice already has, collects the patient signature by text message, and tracks every application through to a decision and renewal.

The programs a primary care office files most are the highest-volume ones in the catalog: anticoagulants, diabetes therapies, cholesterol therapies and maintenance inhalers.
There is usually no dedicated patient assistance coordinator, so the work lands on whoever at the front desk has time that day.
The cost shows up in aggregate across a large panel rather than on any single application, which is why it is easy to under-count and hard to staff for.
Most of these medications are dispensed through a pharmacy, so an approval that never becomes a first fill is invisible to the practice unless someone checks.

### Nobody owns the process

Applications are explicitly routed to whoever holds the next action, so the work does not depend on one person remembering where everything is. A clear queue is what makes a shared front-office team workable.

### The same facts, typed again every time

Demographics, insurance, prescriber NPI and income are stored once, program-independently, so a second application for the same patient reuses everything that has not changed. On a large panel that is where the time actually comes back.

### Preventive therapy stalls on the patient

A patient who feels well deprioritizes paperwork. The patient completes their part from a single-use link sent by text message, with no account to create, which is the step that stalls most applications.

## Patient assistance program software for oncology practices

[Oncology workflow](https://algomeds.com/solutions/oncology/)

Oncology practices run more manufacturer patient assistance applications per patient than almost any other specialty, because regimens combine infused and oral agents from different manufacturers. AlgoMeds fills each manufacturer form from one normalized patient record, collects the patient signature by text message, and tracks every application through to a decision.

A single regimen can involve two or three separate manufacturer programs with different forms, different signature rules and different supporting documents.
Infused agents are usually administered in the practice, so the assistance workflow sits alongside buy-and-bill rather than a retail pharmacy fill.
Oral oncolytics go through specialty pharmacy, which adds a second coordination path for the same patient.
Financial navigators and PAP coordinators are often the same person, and are measured on applications completed per week.

### The same patient, four different forms

Demographics, prescriber NPI, diagnosis and income get re-typed for every agent in the regimen. AlgoMeds stores that data once, program-independently, so the second application for a patient is a fraction of the first.

### Treatment cannot wait for a fax to come back

Applications are tracked from delivery to decision, so nobody has to call a manufacturer hotline to find out whether a form arrived.

### Renewals land in the middle of active therapy

Renewals open ahead of expiry and reuse the prior application, so enrollment does not lapse while a patient is on treatment.

## Patient assistance program software for dermatology practices

[Dermatology workflow](https://algomeds.com/solutions/dermatology/)

Dermatology practices prescribing biologics for psoriasis, atopic dermatitis and hidradenitis suppurativa apply to manufacturer assistance programs on the patient’s behalf. AlgoMeds fills the manufacturer’s actual enrollment form from the chart, gets the patient signature by text message, and tracks the application through to approval and annual renewal.

Biologic assistance is high-volume and repetitive: a mid-size practice may run the same handful of programs dozens of times a year.
Most agents are self-injected or oral, so approved product ships to the patient rather than to the practice.
Switching between agents after a failure restarts the paperwork with a different manufacturer.
The patient signature is the single most common reason an application stalls.

### Patients never send the form back

A single-use, short-lived signature link goes to the patient by text message. No account, no app, no printer, which removes the biggest drop-off point in the process.

### Every switch means starting over

Because the patient record is stored independently of any one program form, moving a patient to a different agent reuses everything that has not changed.

### Annual re-enrollment quietly expires

Renewals open before expiry rather than being discovered when the pharmacy calls.

## Patient assistance program software for rheumatology practices

[Rheumatology workflow](https://algomeds.com/solutions/rheumatology/)

Rheumatology practices apply to manufacturer assistance programs for patients on biologics and targeted synthetic DMARDs who are uninsured or underinsured. AlgoMeds fills each manufacturer enrollment form from the practice record, collects prescriber and patient signatures, and tracks the application through submission, decision and annual renewal.

Patients stay on therapy for years, so renewals, not first applications, are the bulk of the ongoing workload.
Most agents are self-injected or oral and dispensed through specialty pharmacy.
Step therapy means many patients cycle through two or three manufacturers before settling.
A lapse in enrollment shows up as a missed dose, not as an email.

### Renewals outnumber new applications

Renewals carry forward verified data from the prior application instead of starting from a blank form, and optional program enrollments are re-decided rather than silently carried over.

### The coordinator is the whole process

One queue with a clear next action per application, so nothing depends on remembering which patient owes which document.

### Prescriber sections stall on signature

Sections are scoped by role and routed to whoever holds the next action, so a prescriber signs once rather than being pulled back for corrections.

## Patient assistance program software for neurology and MS practices

[Neurology & MS workflow](https://algomeds.com/solutions/neurology/)

Neurology and multiple sclerosis practices apply to manufacturer assistance programs for disease-modifying therapies and migraine preventives on the patient’s behalf. AlgoMeds fills the manufacturer enrollment form from the chart, collects the patient signature by text message, and tracks the application from submission through decision and renewal.

Disease-modifying therapies are among the highest-cost drugs a practice will ever enroll a patient into, so an unsubmitted form has a large financial consequence.
Some agents are infused in an infusion suite; others are self-injected at home. The two paths have different enrollment workflows.
MS care coordinators typically manage a long-tenured panel where renewals dominate.
Patients with mobility or dexterity limitations struggle with paper forms specifically.

### Paper is the wrong channel for this panel

The patient completes their portion on a phone. A signature-only request needs no account at all.

### An infusion appointment is a hard deadline

Status is visible from delivery through decision, so scheduling is not blind.

### Long-tenured patients mean long-lived data

One normalized record underneath every form means years of renewals reuse verified data rather than re-collecting it.

## Patient assistance program software for gastroenterology practices

[Gastroenterology workflow](https://algomeds.com/solutions/gastroenterology/)

Gastroenterology practices treating Crohn’s disease and ulcerative colitis apply to manufacturer assistance programs for biologic and oral therapies. AlgoMeds fills each manufacturer enrollment form from the practice record, collects the patient signature by text message, and tracks the application through submission, decision and annual re-enrollment.

IBD patients often start on an induction schedule, so an enrollment delay directly delays therapy.
The same molecules appear in dermatology and rheumatology, but the diagnosis and prescriber attestations differ.
Patients frequently move between agents after loss of response, restarting paperwork with a new manufacturer.
Infusion and self-injection paths coexist inside one practice.

### Induction schedules do not wait

Applications are routed to whoever holds the next action instead of sitting in an inbox, and tracked to delivery.

### Switching agents restarts the paperwork

A program-independent patient record means only the genuinely new fields have to be collected again.

### Documentation requirements vary by program

Required attachments are driven by what the specific program asks for, so staff are not guessing which income documents to chase.

## Patient assistance program software for HIV care

[HIV care workflow](https://algomeds.com/solutions/hiv-care/)

HIV clinics apply to manufacturer assistance programs for patients who are uninsured or underinsured and not fully covered by ADAP or other payers. AlgoMeds fills the manufacturer enrollment form from the clinic record, collects the patient signature by text message, and tracks the application through submission, decision and renewal.

Assistance often sits alongside ADAP, Ryan White and 340B, so the manufacturer application is one lane of a wider access workflow.
Continuity of therapy is the clinical priority. A lapse is not an administrative inconvenience.
Panels frequently include patients who are hard to reach by mail or landline.
Confidentiality expectations are higher than average, including in outbound messages.

### Reaching the patient is the hard part

Signature requests go by text message with no patient name, no medication and no practice name in the message body.

### A lapse means an interruption in therapy

Renewals open ahead of expiry rather than being discovered at the pharmacy counter.

### Privacy has to hold in every channel

Patient-facing notifications are designed to omit patient names, medication names, and clinical detail; request current controls and evidence during security review.

## Patient assistance program software for ophthalmology practices

[Ophthalmology workflow](https://algomeds.com/solutions/ophthalmology/)

Retina practices apply to manufacturer assistance programs for office-administered anti-VEGF therapy on behalf of patients who are uninsured or underinsured. AlgoMeds fills the manufacturer enrollment form from the practice record, collects the patient signature by text message, and tracks the application through submission and decision.

Therapy is administered in the office on a recurring injection schedule, so assistance runs against a repeating calendar rather than a one-time fill.
Programs for office-administered products often supply replacement product to the practice rather than shipping to the patient.
Patients skew older and are frequently accompanied by a caregiver acting on their behalf.
Missing an injection interval has direct visual consequences, which makes lapse prevention clinical rather than administrative.

### The caregiver is often the one who signs

A verified legal representative has a defined role in the form rather than an informal workaround.

### Injection schedules are unforgiving

Renewals open ahead of expiry and status is visible through to decision.

### Product tracking sits with the practice

Applications for office-administered products are tracked to delivery, with acceptance or denial proof attached to the record.

## Patient assistance program software for pulmonology practices

[Pulmonology workflow](https://algomeds.com/solutions/pulmonology/)

Pulmonology practices apply to manufacturer assistance programs for severe asthma biologics and maintenance inhalers on behalf of patients who are uninsured or underinsured. AlgoMeds fills the manufacturer enrollment form from the practice record, collects the patient signature by text message, and tracks the application through to a decision.

Maintenance inhalers are high-frequency, lower-cost enrollments; biologics are low-frequency, high-value enrollments. The same coordinator handles both.
Biologics may be administered in the office or self-administered at home depending on the agent and the patient.
Adherence gaps caused by cost show up as exacerbations and admissions.
Many practices carry a large panel of patients on the same one or two programs.

### High-volume, low-variety paperwork

Frequently used programs are pinned for one-click starts, and supported fields from the practice record arrive filled and missing information is flagged.

### Cost gaps become exacerbations

Applications are tracked from submission to decision so a stalled form is visible before it becomes a missed refill.

### Two workflows, one coordinator

Office-administered and self-administered programs sit in the same queue with the same next-action model.

## Patient assistance program software for cystic fibrosis care centers

[Cystic fibrosis workflow](https://algomeds.com/solutions/cystic-fibrosis/)

Cystic fibrosis care centers apply to manufacturer assistance programs for CFTR modulator therapy on behalf of patients who are uninsured or underinsured. AlgoMeds fills the manufacturer enrollment form from the center’s record, collects patient or guardian signatures by text message, and tracks the application through submission and renewal.

Care is delivered by a multidisciplinary team, so the person who starts the application is rarely the person who signs it.
Many patients are minors, which means a parent or guardian signs and their authority has to be recorded.
Therapy is continuous and lifelong, a lapse in enrollment is a lapse in treatment.
Center volume is concentrated in a small number of programs, so the workflow repeats constantly.

### A guardian signs, not the patient

Legal representatives have verified authority and a defined role in the form rather than an informal workaround.

### Multidisciplinary teams need one queue

Role-scoped sections and explicit routing mean each person sees only their part and knows when it is their turn.

### Continuous therapy needs continuous enrollment

Renewals open ahead of expiry and reuse the prior application’s verified data.

## Patient assistance program software for cardiology and diabetes care

[Cardiometabolic workflow](https://algomeds.com/solutions/cardiometabolic/)

Cardiology, endocrinology and primary care practices apply to manufacturer assistance programs for anticoagulants, lipid-lowering therapy and diabetes medications on behalf of patients who are uninsured or underinsured. AlgoMeds fills each manufacturer form from the practice record, collects the patient signature by text message, and tracks the application to a decision.

Volume is the defining characteristic: these are common drugs across large panels, not rare-disease one-offs.
Applications are usually run by primary care or a shared care-coordination team rather than a dedicated specialty navigator.
Non-adherence caused by cost is silent, the practice finds out at the next event, not at the pharmacy.
Many patients qualify for assistance only in specific coverage-gap situations, so eligibility has to be checked against the program, not assumed.

### The volume is the problem

Autofill and a program-independent patient record mean the tenth application is dramatically faster than the first.

### No dedicated navigator

A clear next-action queue lets a shared team run the process without one person holding it all in their head.

### Silent non-adherence

Tracking to decision surfaces applications that never landed, before the patient stops filling.

## Patient assistance program software for behavioral health practices

[Behavioral health workflow](https://algomeds.com/solutions/behavioral-health/)

Behavioral health practices apply to manufacturer assistance programs for long-acting injectable antipsychotics and other maintenance therapies on behalf of patients who are uninsured or underinsured. AlgoMeds fills the manufacturer enrollment form from the practice record, collects the patient or representative signature, and tracks the application through to a decision.

Long-acting injectables are administered in the clinic on a fixed interval, so an enrollment gap becomes a missed dose on a known date.
Patients may have a legal representative or case manager acting on their behalf.
Care teams often include community mental health staff who are not part of the prescribing practice.
Reaching patients reliably is frequently the hardest part of the workflow.

### Reaching the patient

Signature requests go by text message, single-use and short-lived, with no patient name or medication in the message body.

### Representatives need a real path

Verified legal representatives have a defined role in the form rather than an undocumented workaround.

### Fixed injection intervals

Renewals open ahead of expiry so a lapse is not discovered on the day of the appointment.

## Patient assistance software for PAP coordinators

[PAP coordinators & office staff workflow](https://algomeds.com/solutions/pap-coordinators/)

A patient assistance coordinator runs manufacturer applications end to end: choosing the right form, filling it, collecting prescriber and patient signatures, attaching income documentation, submitting it, and renewing it before it lapses. AlgoMeds puts all of that in one queue, with supported fields filled from the practice record and missing information flagged for review.

### Current workflow

- You own the whole process manually, and you are the only person who knows where each application actually is.
- The same demographics, NPI, insurance and income facts get typed again on every form, for every drug, every renewal.
- You chase patients by phone for a signature on a form they may never have opened.
- After submission, status can be difficult to verify until the patient or manufacturer follows up.
- Renewals expire quietly and you find out from the pharmacy.

### The form arrives already filled

Pick the medication and the correct current manufacturer form opens pre-filled from the patient chart, prescriber profile, insurance on file and prior submitted applications. Every filled value carries its own provenance, so you can see what was autofilled versus typed.

### Collect the patient section

Send a single-use, short-lived signature link by text message. Identity is verified before anything is disclosed, and no account is required. For patients who want ongoing visibility, a full portal invite is the other option.

### One queue, one next action

Sections are scoped by role and each application is explicitly routed to whoever holds the next action, prescriber, staff, patient or representative, instead of sitting in a shared inbox.

### Track status from one queue

Dashboards show what is open, what is waiting on the patient, what is with the manufacturer and what is approved. Delivery status is tracked back into the application.

### Renewals open before they expire

A renewal reuses the prior application’s verified data rather than starting blank. Optional manufacturer enrollments are never silently carried forward: each one is an explicit decision on the new application.

### Returns come back with an explanation

Documents returned by a manufacturer are matched to the right application, and corrections arrive with a written note explaining what to fix rather than a dead end.

### Do we still do the work, or does AlgoMeds?

You own the clinical decisions, the patient relationship and the prescriber signature. AlgoMeds does the form resolution, the data entry, the patient hand-off, the delivery packet and the tracking. Our operations team handles returned-document matching and delivery plumbing so you do not deal with it program by program.

### How long does it take to get started?

It is browser-based, so there is nothing to install. Onboarding covers practice identity, the account owner, team invitations and then patient panel import from whatever list your EHR exports.

### What happens when a patient will not complete their part?

The application shows explicitly that it is waiting on the patient, and the patient step is a link on a phone rather than a form to print, sign, scan and return. The mobile workflow is designed to reduce a common source of application delay.

## Patient assistance software for prescribers

[Prescribers workflow](https://algomeds.com/solutions/prescribers/)

Prescribers certify the clinical portion of a manufacturer patient assistance application: diagnosis, treatment plan and their own credentials. AlgoMeds presents only the prescriber section, pre-filled from the practice record, as a real signing target on the actual program form, so the prescriber can review the relevant information and reduce avoidable correction cycles.

### Current workflow

- Reviewing a form may require cross-checking information that was entered elsewhere.
- You get pulled back into applications days later for a correction that could have been caught before signing.
- The same certification gets re-signed for every drug and every renewal.
- You have no visibility into whether the patient in front of you actually got the medication you prescribed.

### You see only your section

Sections are scoped by role. The prescriber section shows the clinical content you are certifying, with the provenance of each filled value visible, so signing becomes a focused verification step.

### Sign from any device

Signature areas render as real signing targets on the actual manufacturer form. Programs that accept either of two alternative prescriber signatures are supported, and programs that still require wet ink produce a print-ready packet that is checked back in against what was generated.

### Sign once, not repeatedly

Your profile and credentials populate every form. A renewal carries forward what was verified last time rather than asking for it again.

### See what happened after you signed

Applications are tracked through delivery to decision, with acceptance or denial proof attached to the record.

### How much of a prescriber’s time does this actually take?

The prescriber step is a review and a signature on the section you are certifying. The surrounding workflow coordinates form selection, data entry, the patient hand-off, documentation and submission.

### Does AlgoMeds make any clinical or eligibility determination?

No. AlgoMeds does not determine eligibility, predict approval, or influence a manufacturer’s decision. It fills the manufacturer’s form correctly from your practice’s data and tracks it.

### Can I do this on a phone between patients?

Yes. The platform is mobile-capable throughout: staff can review on a tablet, prescribers can sign on a phone, and patients complete their portion on their own device.

## Patient assistance software for practice administrators

[Practice administrators workflow](https://algomeds.com/solutions/practice-administrators/)

Practice administrators need to know how much staff time patient assistance consumes, who has access to patient data, and whether the practice could evidence that access if asked. AlgoMeds provides throughput reporting, role-based access with a full audit trail, and a HIPAA-aligned architecture with a BAA available.

### Current workflow

- You have no reliable measure of how many staff hours patient assistance consumes each week.
- Access may be fragmented across manufacturer portals, making consistent oversight difficult.
- An audit trail, if one exists, is reconstructed after the fact.
- Every new tool is an IT project you do not have capacity for.

### Measurable throughput

Reporting on applications open, waiting on the patient, with the manufacturer and approved, so staffing decisions can use workflow data rather than informal estimates.

### Access control that stands up to scrutiny

Role-based team management with invitations and activation control, multi-factor enrollment required for clinical workforce roles, and break-glass emergency access that is reviewed after the fact by the account owner.

### A continuous audit trail

Every access and change is audited, who, what, when, and to which record, rather than reconstructed when someone asks.

### Deploy without a custom interface

Browser-based on the machines you already have. Onboarding covers practice identity, account owner, team invitations and patient panel import from whatever list your EHR exports, without requiring a live interface before onboarding.

### Diligence-ready

We maintain a customer security FAQ, a data-flow and boundary document, and an evidence checklist for buyer security review. See the trust page for what we do and do not claim.

### Will you sign a BAA?

Yes. AlgoMeds is built on a HIPAA-aligned architecture and a BAA is available. Details are on the trust and security page.

### Will this work with our EHR?

AlgoMeds imports supported patient-list exports without requiring a live EHR interface. Export formats differ, so we verify your file during a demo, preview rows before import, and flag likely duplicates. Ask us about a custom integration if your workflow needs one.

### How is patient data isolated between practices?

Tenant boundaries are enforced at the database layer and tested in the release suite. Ask for the current architecture and test evidence during security review.

### Can you build something specific to how our group works?

Some group requirements may be addressed through custom integrations, workflows or reporting, including deeper EHR connectivity. We confirm feasibility, scope and current product fit before making a commitment.
